You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company's DETECTR disease detection platform will be used to help develop the technology and optimize the CRISPR enzymes used in the point-of-care device.
In Genome Research this week: transcriptome analysis of canine mammary tumors, collection of small RNAs found in disease-spreading mosquitoes, and more.
The two new tests, which have the capability to quantify a patient's viral load, have been designed without external RNA extraction or amplification steps.
Science reports that Tasmanian devils are passing devil facial tumor disease on to a smaller number of other devils.
In Science this week: CRISPR and expression-reported sequencing approach to trace genetic interactions, sample preparation platform for single-cell sequencing, and more.
The company will use the funding to expand its gene editing systems for potential therapeutic use, and to advance research and validation for its pipeline.
Emmanuelle Charpentier and Jennifer Doudna have won this year's Nobel Prize in Chemistry for their work developing the CRISPR gene editing tool, according to Reuters.
The newly public company has attracted attention from both investors and competitors for its technology platform used in antibody discovery workflows.
The funding will allow the company to accelerate development of its DNA synthesis technology, hire staff, build an R&D facility, and establish industrial partnerships.
The ruling is the latest decision in the fight between the Broad and the University of California for control over the bulk of the IP rights to CRISPR-Cas9.
Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.
Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.
Science reports that a Dutch research funding agency is combating a ransomware attack.
In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.